Microfluidic Osteoarthritis-on-a-Chip: Evaluating Adverse Effects of Tanezumab in Co-Culture

Scott Wood

Associate Professor

University of New England

Scott T. Wood, Ph.D., is Director of the Portland Laboratory for Biotechnology and Health Sciences and Associate Professor of Biomedical Sciences in the College of Osteopathic Medicine at the University of New England. He leads an interdisciplinary research team in developing novel therapeutic strategies for osteoarthritis and innovative drug screening technologies. His research blends foundational cellular mechanobiology studies with applied biotechnology, including the creation of advanced microphysiological systems that model human joint tissue complexity. As Founder and CTO of CellField Technologies, Dr. Wood is commercializing a multi-tissue joint on a chip platform that enhances pre-clinical drug development for complex joint diseases. He holds a B.S. in Mechanical Engineering from Texas Tech University, a M.S. and Ph.D. in Bioengineering from Clemson University, and has been recognized by the NSF CAREER Award and ASME’s Rising Star in Mechanical Engineering Award.